Journal Club 2019-2020 Year to Date Articles
June 25, 2019: Goodsett, Shankar
Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections (CG)
Canagliflozin and Renal Outcomes in Type 2 DM and Nephropathy (AS)
July 9, 2019: Sannapaneni, Kaila

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer (SS)

Procedural Volume and Outcomes for Transcatheter Aortic-Valve Replacement (VK)

July 23, 2019: Sudhekar, Mantha

Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine (NS)

Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy (YM)

August 6, 2019: Harada, Anjum

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation (MH)

Vitamin D Supplementation and Prevention of Type 2 Diabetes (AA)

August 20, 2019: Tayon, Lee

A Multicenter Trial of Vena Cava Filters in Severely Injured Patients (KT)

Vitamin D Enhances the Efficacy of Topical Artifical Tears in Patients with Dry Eye Disease (JL)

September 3, 2019: Florez-Pollack, Mada

Sodium-Glucose Contransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections (SF-P)

C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations (PM)

September 17, 2019: Sannapaneni, Kojder
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy (SS)
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (PK)
October 1, 2019: Ausama, Tumyan
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (LA)
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis (GT)
October 15, 2019: Gupta, Leidner

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis (NG)

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease (JL)
October 29, 2019: Harada, Martinez

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction (MH)

Ligelizumab for Chronic Spontaneous Urticaria (LM)
November 12, 2019: Sudhekar, Abbas

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes (NS)

Polypill for Cardiovascular Disease Prevention in an Underserved Population (SA)

December 3, 2019: Goodsett, Kaila

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial (CG)

Randomized Trial of Medical versus Surgical Treatment of Refractory Heartburn (VK)

December 17, 2019: Anjum, Nyaundi

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel A Randomized Clinical Trial (AA)

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics (TN)

January 14, 2020: Mada, Florez-Pollack

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis (PM)

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (SP)

January 28, 2020: Mantha, Marion

The Efficacy and Safety of Low Dose Colchicine after Myocardial Infarction (YM)

Randomized Trial of Four Treatment Approaches for Actinic Keratosis (TM)

February 11, 2020: Nyaundi, Bajaj

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke (TN)

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type II Diabetes (AB)

February 25, 2020: Ausama, Tumyan

 

 

March 3, 2020: Marion, Tayon

Ligelizumab for Chronic Spontaneous Urticaria (TM)

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation (KT)

March 17, 2020: Gupta, Swanson

 

 

April 7, 2020: Leidner, Bajaj
 
Teprotumumab for the Treatment of Active Thyroid Eye Disease (AB)
April 21, 2020: Lee, Martinez

Trial of Satralizumab in Neuromyelitis Optica Sepctrum Disorder (JL)

 

May 5, 2020: Hudson, Kojder

Six-month Randomized, Multicenter Trial of Closed-loop Control in Type 1 Diabetes (AH)

 

May 19, 2020: Swanson, Hudson

 

 
June 2, 2020: Shankar, Abbas